Skip to main content
. 2015 Dec 16;15:949. doi: 10.1186/s12885-015-1978-2

Fig. 8.

Fig. 8

Trial identification and inclusion in the systematic review of irinotecan-based chemotherapy efficacy in different ethnicities: The literature was selected according to the criteria as follows: (1) NSCLC patients with previously untreated with chemotherapy; (2) treated with irinotecan-based doublet regimen; (3) prospective clinical trials Phase II and III